Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.0K
Genomics02:02

Genomics

39.1K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Early Diagnosis and Therapeutic Discovery in CLN3 Disease: A Computational Biomarker Discovery Framework.

medRxiv : the preprint server for health sciences·2026
Same author

CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic Disorders.

American journal of medical genetics. Part C, Seminars in medical genetics·2026
Same author

Impact of Preexisting Rare Diseases on COVID-19 Severity, Reinfection, and Long COVID, and the Modifying Effects of Vaccination and Antiviral Therapy: A Retrospective Study from the N3C Data Enclave.

medRxiv : the preprint server for health sciences·2025
Same author

Systematic identification of rare disease patients in electronic health records enables evaluation of clinical outcomes.

medRxiv : the preprint server for health sciences·2025
Same author

Novel target identification towards drug repurposing based on biological activity profiles.

PloS one·2025
Same author

Reversal gene expression assessment for drug repurposing, a case study of glioblastoma.

Journal of translational medicine·2025

Related Experiment Video

Updated: Dec 7, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

Phenotypically Similar Rare Disease Identification from an Integrative Knowledge Graph for Data Harmonization:

Qian Zhu1, Dac-Trung Nguyen1, Gioconda Alyea2

  • 1Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, United States.

JMIR Medical Informatics
|October 2, 2020
PubMed
Summary

This study identifies phenotypically similar rare diseases to improve data harmonization. The findings enhance consistency across rare disease resources, supporting translational research and clinical decision-making.

Keywords:
GARDdata harmonizationphenotypical similarityrare diseases

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.0K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K

Related Experiment Videos

Last Updated: Dec 7, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.0K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K

Area of Science:

  • Genomics and Bioinformatics
  • Medical Informatics
  • Rare Disease Research

Background:

  • Standardized protocols for rare disease data harmonization are lacking.
  • Existing resources exhibit data redundancy and inconsistency.
  • This hinders clinical decision-making and education in rare diseases.

Purpose of the Study:

  • To systematically identify phenotypically similar Genetic and Rare Diseases (GARD).
  • To support rare disease data harmonization through knowledge graph analysis.
  • To determine similarity types among GARD diseases.

Main Methods:

  • Programmatic identification of phenotypically similar GARD diseases.
  • Comparison of disease mappings between GARD and other rare disease resources.
  • Derivation of clinical manifestations from disease classifications and prioritization based on phenotypes and genotypes.

Main Results:

  • Validated 87% of identified phenotypically similar disease pairs.
  • Achieved 94% precision and 86% F-measure in similarity identification.
  • Identified 662 phenotypically similar disease pairs for GARD data harmonization.

Conclusions:

  • Successfully identified phenotypically similar rare diseases using two distinct approaches.
  • Results will guide GARD data harmonization and expand translational science.
  • Enhanced data transparency and consistency across rare disease resources.